A new study, which spans multiple countries, found that patients developed blood clotting conditions after receiving the AstraZeneca COVID-19 vaccine at a “similar” rate to those who received the Pfizer/BioNTech jab, say researchers.
A team of researchers from Spain, the UK and the Netherlands compared data from over 1.3 million people vaccinated against COVID in Catalonia, looking for evidence of blood clotting conditions that developed after they received their vaccinations.
“In this study including 1,372,213 people vaccinated against SARS-CoV-2, similar safety profiles were seen for both vaccines,” the researchers wrote in their pre-print paper, which has not been peer-reviewed.
The study also reinforced the far greater risks posed by not getting vaccinated.
READ MORE: Pfizer Covid vaccine: Six ‘persistent symptoms’ of COVID-19 spotted in those fully jabbed
Published at Thu, 29 Jul 2021 15:12:00 +0000